CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 23 enrolled
Drug / intervention
Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo] +2 moredrug
Likely dose
Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo]from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05096312
NCT05096312Phase 4Completed
CompareCT.gov

A Randomized, Double Blind, Placebo-Controlled Clinical Trial of the Effects of Oral Zinc Gluconate Among Diagnosed Acne Vulgaris Patients

East Avenue Medical Center, Philippines·interventional·Posted Oct 27, 2021·Updated May 11, 2022

In Brief

A Phase 4 clinical trial evaluating Zinc gluconate, Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo], and 1 other intervention for Acne Vulgaris. Completed, enrolled 23 participants across 1 site.

Detailed Summary

Acne Vulgaris is one of the most common dermatologic diagnoses requiring long-term maintenance therapy. Promising results of oral zinc gluconate in improving acne vulgaris has been described. A randomized, double blind, placebo-controlled clinical trial was utilized for this study with the objective to assess the efficacy of oral zinc gluconate in the improvement of disease activity in acne vulgaris patients as measured by the inflammatory score and Global Acne Grading System (GAGS) score.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesPhilippines
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedOct 27, 2021
Enrollment StartDec 21, 2018
Primary CompletionJul 19, 2019
Study CompletionJul 20, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 4.7 years ago

Interventions

Zinc gluconatedietary

oral zinc gluconate 200mg

Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo]drug

Adapalene 0.3% + Benzoyl peroxide 2.5% gel applied once daily in the evening

Placeboother

contains cornstarch